AntineoplasticsMyelosuppression: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1847卷 / 1期

关键词：

D O I：

10.1007/s40278-021-92610-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：53 / 53

相关论文

共 50 条

[31] AntineoplasticsMyelosuppression and delirium in an elderly patient: case report
Reactions Weekly, 2011, 1367 (1) : 7 - 7
[32] AntineoplasticsMyelosuppression and COVID-19: case report
Reactions Weekly, 2020, 1835 (1) : 35 - 35
[33] AntineoplasticsMyelosuppression, gingival bleeding and lack of efficacy: case report
Reactions Weekly, 2025, 2055 (1) : 46 - 46
[34] AntineoplasticsMyelosuppression, renal impairment and lack of efficacy: case report
Reactions Weekly, 2023, 1946 (1) : 63 - 63
[35] AntineoplasticsMyelosuppression following off label use: case report
Reactions Weekly, 2021, 1844 (1) : 46 - 46
[36] AntineoplasticsMyelosuppression, cytokine release syndrome and neurotoxicity: case report
Reactions Weekly, 2020, 1795 (1) : 37 - 37
[37] AntineoplasticsMyelosuppression, heart failure and elevated ALT, AST: case report
Reactions Weekly, 2021, 1836 (1) : 88 - 88
[38] AntineoplasticsMyelosuppression, hand-foot syndrome and rash: case report
Reactions Weekly, 2018, 1702 (1) : 32 - 32
[39] AntineoplasticsMyelosuppression, impaired liver function and elevated BP: case report
Reactions Weekly, 2019, 1756 (1) : 44 - 44
[40] AntineoplasticsMyelosuppression: 2 case reports
Reactions Weekly, 2023, 1983 (1) : 60 - 60

← 1 2 3 4 5 →